Henning R Gockel

Summary

Country: Germany

Publications

  1. ncbi request reprint Stable remission after administration of rituximab in a patient with primary hepatic marginal zone B-cell lymphoma
    H R Gockel
    Department of Medicine B, University of Muenster, Muenster, Germany
    Eur J Haematol 74:445-7. 2005
  2. ncbi request reprint [Virus persistence in hepatitis C: lifelong infection despite therapy?]
    Henning R Gockel
    Medizinische Klinik, St Marien Hospital Hamm, Hamm
    Med Klin (Munich) 101:378-83. 2006
  3. ncbi request reprint Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway
    Henning R Gockel
    Department of Medicine B, University of Munster, Muenster, Germany
    J Immunol 172:5103-9. 2004

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Stable remission after administration of rituximab in a patient with primary hepatic marginal zone B-cell lymphoma
    H R Gockel
    Department of Medicine B, University of Muenster, Muenster, Germany
    Eur J Haematol 74:445-7. 2005
    ..This case report demonstrates the difficulties of treating this extremely rare liver disease and shows its response to rituximab therapy...
  2. ncbi request reprint [Virus persistence in hepatitis C: lifelong infection despite therapy?]
    Henning R Gockel
    Medizinische Klinik, St Marien Hospital Hamm, Hamm
    Med Klin (Munich) 101:378-83. 2006
    ..Exciting progress has been achieved by the use of combined therapy regimens with pegylated interferon and ribavirin resulting in sustained virological response rates of 60-80%, depending on the genotype...
  3. ncbi request reprint Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway
    Henning R Gockel
    Department of Medicine B, University of Munster, Muenster, Germany
    J Immunol 172:5103-9. 2004
    ..Our data suggest that thalidomide-induced monocyte apoptosis is at least partially mediated by a mitochondrial signaling pathway and might contribute to the complex immunomodulatory properties of the drug...